Among various immune subsets in TME, T cell subsets such as cytotoxic CD8+ T cells, helper CD4+ T cells, and regulatory CD4+ T cells are recognized as key components in the anti-tumor immune response (13–15). This evidence concerns the gene CD8A and neoplasm.